Evidence for Health II: Overcoming barriers to using evidence in policy and practice

Health Research Policy and Systems

Volumn 14, Issue 1, 2016, Pages

  Andermann, Anne ^a   Pang, Tikki ^b   Newton, John N ^c   Davis, Adrian ^d   Panisset, Ulysses ^e,f  

^a MCGILL UNIVERSITY   (Canada)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Barriers; Decision making; Evidence based medicine; Health policy; Public health; Research

Indexed keywords

CONFLICT OF INTEREST; CONSENSUS DEVELOPMENT; DECISION MAKING; HEALTH CARE POLICY; HUMAN; HUMAN EXPERIMENT; LANGUAGE; PUBLIC HEALTH; PUBLICATION; SCIENTIFIC LITERATURE; SCIENTIST; SYNTHESIS; UNCERTAINTY; EVIDENCE BASED MEDICINE; INFORMATION DISSEMINATION; KNOWLEDGE; MANAGEMENT; ORGANIZATION AND MANAGEMENT; PUBLIC OPINION;

CONFLICT OF INTEREST; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEALTH POLICY; HUMANS; INFORMATION DISSEMINATION; KNOWLEDGE; POLICY MAKING; PUBLIC OPINION;

EID: 84978909905     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/s12961-016-0086-3     Document Type: Review

References (46)

1. Andermann A. Evidence for Health: From Patient Choice to Global Policy. Cambridge: Cambridge University Press; 2013.
2. Rycroft-Malone J. From knowing to doing-from the academy to practice: Comment on "The many meanings of evidence: implications for the translational science agenda in healthcare.". Int J Health Policy Manag. 2013;2(1):45-6.
3. Lehmann U, Gilson L. Action learning for health system governance: the reward and challenge of co-production. Health Policy Plan. 2015;30(8):957-63.
4. Greenhalgh T, Fahy N. Research impact in the community-based health sciences: an analysis of 162 case studies from the 2014 UK Research Excellence Framework. BMC Med. 2015;13:232.
5. Redman S, Haynes A, Williamson A. Research impact: neither quick nor easy. BMC Med. 2015;13:265.
6. Muir Gray JA. Evidence-based Health Care. Edinburgh: Churchill Livingstone; 2001.
7. Safe Use of Internet. Chene-Bourg: Health on the Net Foundation; 2011. http://www.hon.ch/HONcode/Patients/visitor_safeUse2.html. Accessed 11 February 2016.
8. Nutbeam D, Harris E. Theory in a Nutshell: A Practical Guide to Health Promotion Theories. 2nd ed. Sydney: McGraw Hill; 2004.
9. Commission for Health Research on Development. Health Research: Essential Link to Equity in Development. Oxford: Oxford University Press; 1990.
10. Brach C, Lenfestey N, Roussel A, Amoozegar J, Sorenson A. RTI International. Will It Work Here? A Decisionmaker's Guide to Adopting Innovations. Rockville: Agency for Healthcare Research and Quality; 2008. https://innovations.ahrq.gov/sites/default/files/guides/InnovationAdoptionGuide.pdf. Accessed 11 February 2016.
11. Garba S, Ahmed A, Mai A, Makama G, Odigie V. Proliferations of scientific medical journals: a burden or a blessing. Oman Med J. 2010;25(4):311-4.
12. Mavriplis C, Thériault G. The periodic health examination: a comparison of United States and Canadian recommendations (French). Can Fam Physician. 2006;52:58-63.
13. Finkel M. Understanding the Mammography Controversy: Science, Politics and Breast Cancer Screening. Westport: Praeger Publishers; 2005.
14. Olsen O, Gøtzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2001;4:CD001877.
15. Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, et al. Effect of population-based screening on breast cancer mortality. Lancet. 2011;378(9805):1775-6.
16. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011;1:CD001877.
17. Gotzsche P, Hartling O, Nielsen M, Broderson J, Jorgensen K. Breast screening: the facts-or maybe not. BMJ. 2009;338:b86.
18. Subjectivity in data analysis. Lancet. 1991;337(8738):401-2.
19. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12:18-23.
20. Tong EK, Glantz SA. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Circulation. 2007;116(16):1845-54.
21. Chapman S, Shatenstein S. The ethics of the cash register: taking tobacco research dollars. Tob Control. 2001;10(1):1-2.
22. Tong EK, England L, Glantz SA. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry. Pediatrics. 2005;115(3):e356-66.
23. Lexchin J. Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications. Sci Eng Ethics. 2012;18(2):247-61.
24. Omobowale EB, Kuziw M, Naylor MT, Daar AS, Singer PA. Addressing conflicts of interest in Public Private Partnerships. BMC Int Health Hum Rights. 2010;10:19.
25. Harper Government Invests in Personalized Medicine [press release]. Genome Canada. 2012. http://www.genomecanada.ca/en/about/news.aspx?i=409. Accessed 11 February 2016.
26. Wade N. A Decade Later, Genetic Map Yields Few New Cures. New York Times. 2010 (June 13). http://www.nytimes.com/2010/06/13/health/research/13genome.html. Accessed 11 February 2016.
27. Nuffield Council on Bioethics. Medical Profiling and Online Medicine: The Ethics of 'Personalised Healthcare' in a Consumer Age. London: Nuffield Council on Bioethics; 2010. http://nuffieldbioethics.org/project/personalised-healthcare-0/. Accessed 11 February 2016.
28. Kazan-Allen L. The asbestos war. Int J Occup Environ Health. 2003;9(3):173-93.
29. Attaran A, Boyd D, Stanbrook M. Asbestos mortality: a Canadian export. CMAJ. 2008;179(9):871-4.
30. Madrazo-Lajous A, Guerrero-Alcántara A. Undue tobacco industry interference in tobacco control policies in Mexico. Salud Publica Mex. 2012;54(3):315-22.
31. Van Lerberghe W, Evans T, Rasanathan K, Mechbal A, Andermann A, Evans D, et al. World Health Report 2008 - Primary Health Care: Now More than Ever. Geneva: World Health Organization; 2008. http://www.who.int/whr/2008/en/. Accessed 11 February 2016.
32. Hozumi D, Frost L, Suraratdecha C, Pratt B, Sezgin Y, Reichenbach L, et al. The Role of the Private Sector in Health: A Landscape Analysis of Global Players' Attitudes toward the Private Sector in Health Systems and Policy Levers That Influence These Attitudes. New York: The Rockefeller Foundation; 2008. http://www.resultsfordevelopment.org/sites/resultsfordevelopment.org/files/resources/A%20Landscape%20Analysis%20of%20Global%20Attitudes%20toward%20the%20Private%20Sector.pdf. Accessed 11 February 2016.
33. Whitehead M, Dahlgren G, Evans T. Equity and health sector reforms: can low-income countries escape the medical poverty trap? Lancet. 2001;358(9284):833-6.
34. Tipping G. The social impact of user fees for health care on poor households: commissioned report to the Ministry of Health. Hanoi: Ministry of Health; 2000.
35. Stuckler D, King L, McKee M. Mass privatisation and the post-communist mortality crisis: a cross-national analysis. Lancet. 2009;373(9661):399-407.
36. Rowden R. The ghosts of user fees past: exploring accountability for victims of a 30-year economic policy mistake. Health Hum Rights. 2013;15(1):E175-85.
37. The Cochrane Collaboration. http://www.cochrane.org. Accessed 11 February 2016.
38. International Network of Agencies for Health Technology Assessment (INAHTA). http://www.inahta.net/. Accessed 11 February 2016.
39. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada; 1994.
40. US Preventive Services Task Force (USPSTF). Guide to Clinical Preventive Services, 2010-2011. Rockville: Agency for Healthcare Research and Quality; 2010. http://www.ahrq.gov/clinic/pocketgd.htm. Accessed 11 February 2016.
41. Community Preventive Services Task Force. The Guide to Community Preventive Services: What Works to Promote Health. Oxford: Oxford University Press; 2005. http://www.thecommunityguide.org/library/book/index.html. Accessed 11 February 2016.
42. Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards systematic reviews that inform healthcare management and policymaking. J Health Serv Res Policy. 2005;10 Suppl 1:35-48.
43. Waters E, Armstrong R, Swinburn B, Moore L, Dobbins M, Anderson L, et al. An exploratory cluster randomised controlled trial of knowledge translation strategies to support evidence-informed decision-making in local governments (The KT4LG study). BMC Public Health. 2011;11:34.
44. EVIPNet Portal. Geneva: World Health Organization; 2012. http://www.evipnet.org/modules/dia/index.php?where=POLICYBRIEF. Accessed 11 February 2016.
45. Longer Lives/Healthier Lives. London: Public Health England; 2014. http://healthierlives.phe.org.uk/topic/mortality. Accessed 11 February 2016.
46. The Cochrane Collaboration. Cochrane Summaries. Oxford: The Cochrane Collaboration; 2012. http://summaries.cochrane.org/. Accessed 11 February 2016.